Abstract
We report the progress of a project at King’s College London funded by UK Healthcare Charity, the Wellcome Trust, to develop a prototype, portable medicines authentication device based on nuclear quadrupole resonance spectroscopy (NQR) and employing innovative parametric data processing, for the non-invasive, non-destructive and quantitative inspection of packaged medicines. The first-generation system will target nitrogen- and/or chlorine-containing medicines in blister packs and bottles without the need to remove these items from their packaging. Initial proof of principle will be based around a database consisting of the NQR “fingerprints” of a select list of essential medicines as defined by the World Health Organization that are commonly counterfeited in developing countries. This database will be expanded as the project progresses, and as the device is taken up for commercialization.
Similar content being viewed by others
Notes
Available to download at: http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
References
WHO and partners accelerate fight against counterfeit medicines. World Health Organization news release. Nov 15, 2006
A.I. Wertheimer, J. Norris, Res. Social Admin. Pharm. 5, 4–16 (2009)
“Opinion Formers’ Conference on Counterfeit Medicines: Perspectives and Action”, the Wellcome Trust and the American Pharmaceutical Group, Conference Report and Briefing, http://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/Counterfeit-medicines/index.htm. Accessed 18 Nov 2009
“Pharmaceutical Products—information and safety measures proposed by the EU.”, published online December 2008, http://ec.europa.eu/news/business/081210_1_en.htm
“European Commission—Counterfeit Medicines”, published online June 2009, http://ec.europa.eu/enterprise/pharmaceuticals/counterf_par_trade/counterfeit_en.htm
“Millions of counterfeit drugs seized in the EU”, published online December 2008, http://www.neurope.eu/articles/91132.php
J. Brant, R. Malpani, Eye on the Ball: Medicine regulation—not IP enforcement—can best deliver quality medicines, Briefing Paper, Oxfam UK, Feb 2011
“Ensuring the Quality of Medicines in Resource-Limited Countries”, report, United States Pharmacopeia Drug Quality and Information Program, 2007
M.B. Lopes, J.-C. Wolff, J.M. Bioucas-Dias, M.A.T. Figueiredo, Anal. Chim. Acta 641, 46–51 (2009)
H. Wu, E.J. Heilweil, A.S. Hussain, M.A. Khan, Inter. J. Pharm. 343, 148–158 (2007)
C. Ricci, L. Nyadong, F. Yang, F.M. Fernandez, C.D. Brown, P.N. Newton, S.G. Kazarian, Anal. Chim. Acta 623, 178–186 (2008)
C. Eliasson, P. Matousek, Anal. Chem. 79, 1696–1701 (2007)
E. Balchin, D.J. Malcolme-Lawes, I.J.F. Poplett, M.D. Rowe, J.A.S. Smith, G.E.S. Pearce, S.A.C. Wren, Anal. Chem. 77, 3925–3930 (2005)
E. Tate, K. Althoefer, J. Barras, M.D. Rowe, J.A.S. Smith, G.E.S. Pearce, S.A.C. Wren, Anal. Chem. 81, 5574–5576 (2009)
The Merck Index, 14th edn. (Merck Publishing Group, USA, 2006)
R. Blinc, J. Seliger, A. Zidanšek, V. Žagar, F. Milia, H. Robert, Solid State NMR 30, 61–68 (2006)
J. Seliger, V. Žagar, J.N. Latosińska, Phys. Chem. Chem. Phys. 12, 13007–13019 (2010)
S.C. Perez, L. Cerioni, A.E. Wolfenson, S. Faudoni, S.L. Cuffini, Intl. J. Pharm. 298, 143–152 (2005)
J. Pirnat, J. Lužnik, V. Jazbinšek, V. Žagar, J. Seliger, T.M. Klapötke, Z. Trontelj, Chem. Phys. 364, 98–104 (2009)
J.N. Latosińska, J. Pharm. Biomed. Anal. 38, 577–587 (2005)
S.D. Somasundaram, A. Jakobsson, M.D. Rowe, J.A.S. Smith, N.R. Butt, K. Althoefer, IEEE Trans. Signal Process. 56, 4221–4229 (2008)
D. Stephenson, J.A.S. Smith, Proc. R. Soc. Lond. A 416, 149–178 (1988)
S.L. Wilcke, E.J. Cairns, J.A. Reimer, Solid State Nucl. Magn. Reson. 29, 199–203 (2006)
M.-Y. Liao, D.B. Zax, J. Phys. Chem. 100, 1483–1487 (1996)
A.J. Rossini, H. Hamaed, R.W. Schurko, J. Magn. Reson. 206, 33–40 (2010)
A.S. Peshkovsky, J. Forguez, L. Cerioni, D.J. Pusiol, J. Magn. Reson. 177, 67–73 (2005)
M. Ostafin, B. Nogaj, Measurement 40, 43–54 (2007)
R. Turner, J. Phys. D 19, L147–L151 (1986)
J.C. Burley, J. van der Streek, P.W. Stephens, Acta Crys. E62, 797–799 (2006)
Acknowledgments
We thank Dr David Stephenson of the University of the West Indies for providing us with double-resonance data. Funding for the project is provided by the Wellcome Trust (http://www.wellcome.org.uk) under their Technology Transfer Award scheme. We also thank AstraZeneca UK and Merck, Sharp & Dohme for funding early experiments at King’s College London in this area.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barras, J., Althoefer, K., Rowe, M.D. et al. The Emerging Field of Medicines Authentication by Nuclear Quadrupole Resonance Spectroscopy. Appl Magn Reson 43, 511–529 (2012). https://doi.org/10.1007/s00723-012-0320-2
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00723-012-0320-2